John D. Shulman - 18 Oct 2021 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: Director, 10%+ Owner
Signature: [see signatures attached as Exhibit 99.2]
Issuer symbol: PTPI
Transactions as of: 18 Oct 2021
Net transactions value: +$2,849,999
Form type: 4
Filing time: 21 Oct 2021, 08:47:14 UTC
Next filing: 30 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTPI	Common Stock, par value $0.0001 per share	Purchase	$2,849,999	+1,661,807	+49%	$1.72	5,057,771	18 Oct 2021	See Footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTPI	Warrant	Purchase	$0	+1,661,807		$0.000000	1,661,807	18 Oct 2021	Common Stock	1,661,807	$1.72	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	See Note (1) in Exhibit 99.1.
F2	Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.